Solesence, Common Stock Stock Performance
| SLSN Stock | 1.89 0.09 5.00% |
The entity has a beta of 0.83, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Solesence, Common's returns are expected to increase less than the market. However, during the bear market, the loss of holding Solesence, Common is expected to be smaller as well. At this point, Solesence, Common Stock has a negative expected return of -0.64%. Please make sure to validate Solesence, Common's jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Solesence, Common Stock performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Solesence, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
1 | Insider Trading | 10/10/2025 |
2 | Nanocatalysts Market Size to Worth USD 7.30 Billion by 2035 | 11/28/2025 |
| Begin Period Cash Flow | 1.7 M | |
| Total Cashflows From Investing Activities | -4.6 M |
Solesence, | Build AI portfolio with Solesence, Stock |
Solesence, Common Relative Risk vs. Return Landscape
If you would invest 331.00 in Solesence, Common Stock on September 26, 2025 and sell it today you would lose (142.00) from holding Solesence, Common Stock or give up 42.9% of portfolio value over 90 days. Solesence, Common Stock is currently does not generate positive expected returns and assumes 7.2134% risk (volatility on return distribution) over the 90 days horizon. In different words, 64% of stocks are less volatile than Solesence,, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Solesence, Common Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Solesence, Common's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Solesence, Common Stock, and traders can use it to determine the average amount a Solesence, Common's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0883
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SLSN |
Based on monthly moving average Solesence, Common is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Solesence, Common by adding Solesence, Common to a well-diversified portfolio.
Solesence, Common Fundamentals Growth
Solesence, Stock prices reflect investors' perceptions of the future prospects and financial health of Solesence, Common, and Solesence, Common fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Solesence, Stock performance.
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.056 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 300.45 M | ||||
| Shares Outstanding | 70.1 M | ||||
| Price To Book | 18.46 X | ||||
| Price To Sales | 5.16 X | ||||
| Revenue | 52.35 M | ||||
| Gross Profit | 15.99 M | ||||
| EBITDA | 6.06 M | ||||
| Net Income | 4.24 M | ||||
| Total Debt | 15.3 M | ||||
| Book Value Per Share | 0.22 X | ||||
| Cash Flow From Operations | 1.97 M | ||||
| Earnings Per Share | 0.05 X | ||||
| Market Capitalization | 294.43 M | ||||
| Total Asset | 50 M | ||||
| Retained Earnings | (100.43 M) | ||||
| Working Capital | 3.58 M | ||||
About Solesence, Common Performance
By examining Solesence, Common's fundamental ratios, stakeholders can obtain critical insights into Solesence, Common's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Solesence, Common is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 204.58 | 109.45 | |
| Return On Tangible Assets | 0.08 | 0.09 | |
| Return On Capital Employed | 0.21 | 0.22 | |
| Return On Assets | 0.08 | 0.09 | |
| Return On Equity | 0.28 | 0.30 |
Things to note about Solesence, Common Stock performance evaluation
Checking the ongoing alerts about Solesence, Common for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Solesence, Common Stock help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Solesence, Common generated a negative expected return over the last 90 days | |
| Solesence, Common has high historical volatility and very poor performance | |
| Solesence, Common may become a speculative penny stock | |
| Solesence, Common is unlikely to experience financial distress in the next 2 years | |
| About 74.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Evans Chigounis Featured in New Spotlight Article Highlighting His Call for Stronger Community Connections Through Nature and Music |
- Analyzing Solesence, Common's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Solesence, Common's stock is overvalued or undervalued compared to its peers.
- Examining Solesence, Common's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Solesence, Common's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Solesence, Common's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Solesence, Common's stock. These opinions can provide insight into Solesence, Common's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Solesence, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solesence, Common. If investors know Solesence, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solesence, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Earnings Share 0.05 | Revenue Per Share | Quarterly Revenue Growth 0.482 | Return On Assets |
The market value of Solesence, Common Stock is measured differently than its book value, which is the value of Solesence, that is recorded on the company's balance sheet. Investors also form their own opinion of Solesence, Common's value that differs from its market value or its book value, called intrinsic value, which is Solesence, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solesence, Common's market value can be influenced by many factors that don't directly affect Solesence, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solesence, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Solesence, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solesence, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.